Prostate Cancer
New prostate cancer data have been reported by researchers in Italy, Canada and Germany
Published in Hospital Law Weekly, November 16th, 2006
Study 1: Permanent interstitial brachytherapy (IB) has a low impact on quality of life (QoL) in patients with localized prostate cancer (LPC).
According to recent research published in the International Journal of Radiation Oncology Biology Physics, "Permanent IB has become an increasingly appealing therapeutic option for LPC among physicians and patients because it involves short hospitalization and treatment and its postulated low degree of toxicity may reduce its impact on the patients' QoL. The aim of this prospective study was to assess the impact of IB on the QoL of patients...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Law Weekly
Source: Hospital Law Weekly (2006-11-16)
More Articles from Hospital Law Weekly
- End-of-Life Issues
Initiative provides advance care directives to ethnically and culturally diverse communities - Epidemiology
Researchers from Monash University, Department of Epidemiology publish findings in epidemiology - Gene Therapy Policy
Policymaking process in Japan for gene therapy is appraised - Legal Issues
MedCom USA subsidiary Card Activation Technologies initiates patent infringement lawsuits - Personnel
St. Jude Medical names Mark D. Carlson chief medical officer, senior VP of clinical affairs - Psychiatry
New research on psychiatry from University of Pennsylvania, Center for Mental Health Policy and Services Research summarized - More from this issue of Hospital Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
